Mumbai, June 4 (Udaipur Kiran): Bliss GVS Pharma is currently trading at Rs. 442.40, up by 7.65 points or 1.76% from its previous closing of Rs. 434.75 on the BSE.
The scrip opened at Rs. 436.90 and has touched a high and low of Rs. 447.35 and Rs. 429.25 respectively. So far 173815 shares were traded on the counter.
The BSE group ‘B’ stock of face value Rs. 1 has touched a 52 week high of Rs. 447.35 on 03-Jun-2026 and a 52 week low of Rs. 118.35 on 10-Nov-2025.
Last one week high and low of the scrip stood at Rs. 447.35 and Rs. 265.30 respectively. The current market cap of the company is Rs. 4622.98 crore.
The promoters holding in the company stood at 35.36%, while Institutions and Non-Institutions held 15.49% and 49.15% respectively.
Bliss GVS Pharma has secured an Inspection Closure Report from the World Health Organization (WHO) for its manufacturing facility located in Palghar (East), Maharashtra. The facility has been confirmed to be in compliance with the Good Manufacturing Practices (GMP) standards published by the WHO.
Bliss GVS Pharma is a fast-growing Pharmaceutical Company with a proven track record of developing, manufacturing and marketing high quality pharmaceutical formulations at affordable prices for the global market.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.